December 8, 2019

Novartis to buy The Medicines Company for $9.7 billion - Daily Leader Extra : Business

default avatar
Welcome to the site! Login or Signup below.
|
||
Logout|My Dashboard

Novartis to buy The Medicines Company for $9.7 billion

Print
Font Size:
Default font size
Larger font size

Posted: Monday, November 25, 2019 3:22 pm

Swiss pharmaceutical company Novartis has reached a deal to buy cholesterol drugmaker The Medicines Co. for $9.7 billion.

Novartis will pay $85 per share for the New Jersey biotech company, a sharp increase over The Medicine Co.'s Friday closing price of $68.55 per share. The deal is worth $9.7 billion, including outstanding stock options and convertible debt.

The Medicines Co. is in late-stage studies of a drug, inclisiran, meant to lower cholesterol.

Novartis has a pattern of acquiring other companies in recent years to expand its portfolio of drugs.

"We're hoping to reimagine treatment of the leading global cause of death. This could be a strong step forward in Novartis' transformation into a focused medicines company," Novartis CEO Vas Narasimhan tweeted Sunday.

The Medicines Co. focuses on researching treatments for cardiovascular disease, specifically looking at ways to lower so-called bad cholesterol.

The deal is expected to close early next year.

© 2019 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Business Videos

Stocks